ReP USP - Resultado da busca

Artigo de periodico
Characterization of patients with dermatomyositis according to anti-melanoma differentiation-associated gene-5 autoantibodies in Centers from 3 Latin American Countries: a cohort study (2022)
Pallo, Pablo Arturo Olivo; Hoff, Leonardo Santos; Borges, Isabela Bruna Pires; Torres-Ruiz, Jiram; Cassiano-Quezada, Fabiola; Granel, Amelia; Gomez, Graciela; Pisoni, Cecilia; Gomez, Ramiro; Shinjo, Samuel Katsuyuki
Fonte: Jcr-journal of clinical rheumatology. Unidade: FM
Assuntos: MIOSITE, ESTUDOS DE COORTES, DOENÇAS PULMONARES INTERSTICIAIS, DOENÇA PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALLO, Pablo Arturo Olivo et al. Characterization of patients with dermatomyositis according to anti-melanoma differentiation-associated gene-5 autoantibodies in Centers from 3 Latin American Countries: a cohort study. Jcr-journal of clinical rheumatology, v. 28, n. 2, p. E444-E448, 2022Tradução . . Disponível em: https://doi.org/10.1097/RHU.0000000000001756. Acesso em: 02 jun. 2024.
APA
Pallo, P. A. O., Hoff, L. S., Borges, I. B. P., Torres-Ruiz, J., Cassiano-Quezada, F., Granel, A., et al. (2022). Characterization of patients with dermatomyositis according to anti-melanoma differentiation-associated gene-5 autoantibodies in Centers from 3 Latin American Countries: a cohort study. Jcr-journal of clinical rheumatology, 28( 2), E444-E448. doi:10.1097/RHU.0000000000001756
NLM
Pallo PAO, Hoff LS, Borges IBP, Torres-Ruiz J, Cassiano-Quezada F, Granel A, Gomez G, Pisoni C, Gomez R, Shinjo SK. Characterization of patients with dermatomyositis according to anti-melanoma differentiation-associated gene-5 autoantibodies in Centers from 3 Latin American Countries: a cohort study [Internet]. Jcr-journal of clinical rheumatology. 2022 ; 28( 2): E444-E448.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1097/RHU.0000000000001756
Vancouver
Pallo PAO, Hoff LS, Borges IBP, Torres-Ruiz J, Cassiano-Quezada F, Granel A, Gomez G, Pisoni C, Gomez R, Shinjo SK. Characterization of patients with dermatomyositis according to anti-melanoma differentiation-associated gene-5 autoantibodies in Centers from 3 Latin American Countries: a cohort study [Internet]. Jcr-journal of clinical rheumatology. 2022 ; 28( 2): E444-E448.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1097/RHU.0000000000001756
Artigo de periodico
Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial (2022)
Baptista, Marcella Vassao de Almeida; Silva, Lais Teodoro da; Samer, Sadia; Oshiro, Telma Miyuki; Shytaj, Iart Luca; Giron, Leila B.; Pena, Nathalia Mantovani; Cruz, Nicolly; Cunha Neto, Edecio ; Duarte, Alberto José da Silva
Fonte: Aids research and therapy. Unidade: FM
Assuntos: HIV, IMUNOGENICIDADE DA VACINA, CÉLULAS DENDRÍTICAS, SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAPTISTA, Marcella Vassao de Almeida et al. Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial. Aids research and therapy, v. 19, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12981-021-00426-z. Acesso em: 02 jun. 2024.
APA
Baptista, M. V. de A., Silva, L. T. da, Samer, S., Oshiro, T. M., Shytaj, I. L., Giron, L. B., et al. (2022). Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial. Aids research and therapy, 19( 1). doi:10.1186/s12981-021-00426-z
NLM
Baptista MV de A, Silva LT da, Samer S, Oshiro TM, Shytaj IL, Giron LB, Pena NM, Cruz N, Cunha Neto E, Duarte AJ da S. Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial [Internet]. Aids research and therapy. 2022 ; 19( 1):[citado 2024 jun. 02 ] Available from: https://doi.org/10.1186/s12981-021-00426-z
Vancouver
Baptista MV de A, Silva LT da, Samer S, Oshiro TM, Shytaj IL, Giron LB, Pena NM, Cruz N, Cunha Neto E, Duarte AJ da S. Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial [Internet]. Aids research and therapy. 2022 ; 19( 1):[citado 2024 jun. 02 ] Available from: https://doi.org/10.1186/s12981-021-00426-z
Artigo de periodico
Obstructive sleep apnea, sleep duration and chronic kidney disease in patients with coronary artery disease (2021)
Furlan, Sofia F; Sinkunas, Viktor; Damiani, Lucas P; Santos, Ronaldo B; Peres, Matheus; Lemos, Pedro A; Lee, Chi-Hang; Lorenzi Filho, Geraldo ; Drager, Luciano Ferreira
Fonte: Sleep medicine. Unidade: FM
Assuntos: TRANSTORNOS DO SONO, APNEIA DO SONO TIPO OBSTRUTIVA, RIM, INSUFICIÊNCIA RENAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FURLAN, Sofia F et al. Obstructive sleep apnea, sleep duration and chronic kidney disease in patients with coronary artery disease. Sleep medicine, v. 84, p. 268-274, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sleep.2021.05.025. Acesso em: 02 jun. 2024.
APA
Furlan, S. F., Sinkunas, V., Damiani, L. P., Santos, R. B., Peres, M., Lemos, P. A., et al. (2021). Obstructive sleep apnea, sleep duration and chronic kidney disease in patients with coronary artery disease. Sleep medicine, 84, 268-274. doi:10.1016/j.sleep.2021.05.025
NLM
Furlan SF, Sinkunas V, Damiani LP, Santos RB, Peres M, Lemos PA, Lee C-H, Lorenzi Filho G, Drager LF. Obstructive sleep apnea, sleep duration and chronic kidney disease in patients with coronary artery disease [Internet]. Sleep medicine. 2021 ; 84 268-274.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1016/j.sleep.2021.05.025
Vancouver
Furlan SF, Sinkunas V, Damiani LP, Santos RB, Peres M, Lemos PA, Lee C-H, Lorenzi Filho G, Drager LF. Obstructive sleep apnea, sleep duration and chronic kidney disease in patients with coronary artery disease [Internet]. Sleep medicine. 2021 ; 84 268-274.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1016/j.sleep.2021.05.025
Artigo de periodico
Effects of the poly(ADP-RIBOSE) polymerase inhibitor olaparib in cerulein-induced pancreatitis (2020)
Ahmad, Akbar; Mello, Aline Haas De; Szczesny, Bartosz; Toro, Gabor; Marcatti, Michela; Druzhyna, Nadiya; Liaudet, Lucas; Tarantini, Stefano; Salomao, Reinaldo; Soriano, Francisco Garcia ; Szabo, Csaba
Fonte: Shock. Unidade: FM
Assuntos: LINHAGEM CELULAR, CÉLULAS EPITELIAIS, CAMUNDONGOS, PANCREATITE, CULTURA DE CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AHMAD, Akbar et al. Effects of the poly(ADP-RIBOSE) polymerase inhibitor olaparib in cerulein-induced pancreatitis. Shock, v. 53, n. 5, p. 653-665, 2020Tradução . . Disponível em: https://doi.org/10.1097/SHK.0000000000001402. Acesso em: 02 jun. 2024.
APA
Ahmad, A., Mello, A. H. D., Szczesny, B., Toro, G., Marcatti, M., Druzhyna, N., et al. (2020). Effects of the poly(ADP-RIBOSE) polymerase inhibitor olaparib in cerulein-induced pancreatitis. Shock, 53( 5), 653-665. doi:10.1097/SHK.0000000000001402
NLM
Ahmad A, Mello AHD, Szczesny B, Toro G, Marcatti M, Druzhyna N, Liaudet L, Tarantini S, Salomao R, Soriano FG, Szabo C. Effects of the poly(ADP-RIBOSE) polymerase inhibitor olaparib in cerulein-induced pancreatitis [Internet]. Shock. 2020 ; 53( 5): 653-665.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1097/SHK.0000000000001402
Vancouver
Ahmad A, Mello AHD, Szczesny B, Toro G, Marcatti M, Druzhyna N, Liaudet L, Tarantini S, Salomao R, Soriano FG, Szabo C. Effects of the poly(ADP-RIBOSE) polymerase inhibitor olaparib in cerulein-induced pancreatitis [Internet]. Shock. 2020 ; 53( 5): 653-665.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1097/SHK.0000000000001402
Artigo de periodico
Immunophenotypical characterization of a brazilian POIS (Post-Orgasmic Illness Syndrome) patient: adding more pieces to puzzle (2020)
Amicis, Karine De; Costa, Priscilla Ramos; Figo, Daniele Danella; Lima, Cynthia Mafra Fonsecade De; Castro, Fabio Fernandes Morato; Kalil Filho, Jorge Elias ; Santos, Keity Souza ; Galvao, Clovis Eduardo Santos
Fonte: Journal of sex & marital therapy. Unidade: FM
Assuntos: DEPRESSÃO, HIPERSENSIBILIDADE, IMUNOLOGIA, BRASILEIROS, IMUNOFENOTIPAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMICIS, Karine De et al. Immunophenotypical characterization of a brazilian POIS (Post-Orgasmic Illness Syndrome) patient: adding more pieces to puzzle. Journal of sex & marital therapy, v. 46, n. 3, p. 227-233, 2020Tradução . . Disponível em: https://doi.org/10.1080/0092623X.2019.1677835. Acesso em: 02 jun. 2024.
APA
Amicis, K. D., Costa, P. R., Figo, D. D., Lima, C. M. F. D., Castro, F. F. M., Kalil Filho, J. E., et al. (2020). Immunophenotypical characterization of a brazilian POIS (Post-Orgasmic Illness Syndrome) patient: adding more pieces to puzzle. Journal of sex & marital therapy, 46( 3), 227-233. doi:10.1080/0092623X.2019.1677835
NLM
Amicis KD, Costa PR, Figo DD, Lima CMFD, Castro FFM, Kalil Filho JE, Santos KS, Galvao CES. Immunophenotypical characterization of a brazilian POIS (Post-Orgasmic Illness Syndrome) patient: adding more pieces to puzzle [Internet]. Journal of sex & marital therapy. 2020 ; 46( 3): 227-233.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1080/0092623X.2019.1677835
Vancouver
Amicis KD, Costa PR, Figo DD, Lima CMFD, Castro FFM, Kalil Filho JE, Santos KS, Galvao CES. Immunophenotypical characterization of a brazilian POIS (Post-Orgasmic Illness Syndrome) patient: adding more pieces to puzzle [Internet]. Journal of sex & marital therapy. 2020 ; 46( 3): 227-233.[citado 2024 jun. 02 ] Available from: https://doi.org/10.1080/0092623X.2019.1677835

Unidades USP

ReP

Filtros

Autores

Autores USP

Assuntos

Agência de fomento